lymphoma

Clinical Images

Right Atrial Mass Biopsy Using Endobronchial Forceps

02/01/2023

Nahyr S. Lugo-Fagundo, MD; Jordan Ray, MD; Peter Pollak, MD; Charles Ritchie, MD; Abdallah El Sabbagh, MD

Nahyr S. Lugo-Fagundo, MD; Jordan Ra...

An endobronchial alligator forceps was used to biopsy an RA mass under intracardiac echocardiographic guidance.

An endobronchial alligator...

02/01/2023

Journal of Invasive Cardiology

Review

Risk of Anaplastic Large-Cell Lymphoma in Cases of Late Seroma Formation After Breast Implant Insertion

08/16/2021

Kun Hwang

Hun Kim

Hyung Mook Kim

Joo Ho Kim

Breast implant–associated ALCL has recently come to the attention of clinicians.

Breast implant–associated ALCL...

08/16/2021

ePlasty

News

IBD Treatment Could Increase Risk of Lymphoma

11/08/2017

The risk of lymphoma has been reported to be higher among patients with IBD receiving thiopurines. In a recent study, researchers sought to further investigate this risk among patients with IBD with various exposures to pharmacological...

The risk of lymphoma has been...

11/08/2017

Advances in Inflammatory Bowel Disease Network

Research in Review

Factors Associated With Early Death Among Elderly Patients With Lymphoma

09/14/2016

JCP Editors

Administrative and cancer registry data, routinely integrated within modern electronic medical records, can help determine which patients with lymphoma are at the highest risk of dying from chemotherapy, according to...

...

09/14/2016

Journal of Clinical Pathways

Research in Review

Bortezomib Regimen More Cost Effective Than Current Standard for Mantle Cell Lymphoma

08/05/2016

JCP Editors

Bortezomib plus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (VR-CAP) may be a more cost-effective treatment option in the United Kingdom for patients with previously untreated mantle cell...

...

08/05/2016

Journal of Clinical Pathways

Research in Review

Anthracycline-based Regimens Improve Survival in Elderly Patients With Lymphoma

07/13/2016

JCP Editors

Findings from a single-center analysis have shown that anthracycline-based therapies may produce better outcomes in patients age 80 years and older with diffuse large B-cell lymphoma (DLBCL), supporting data reported...

...

07/13/2016

Journal of Clinical Pathways

Research in Review

Drug Combinations Cost-Effective for Reducing Febrile Neutropenia in Patients With Non-Hodgkin Lymphoma

03/08/2016

JCP Editors

A study comparing seven prophylaxis strategies for reducing the risk of febrile neutropenia (FN) in patients with non-Hodgkin lymphoma receiving chemotherapy found that routine primary prophylaxis (PP) with...

...

03/08/2016

Journal of Clinical Pathways